Oral BG-12 in multiple sclerosis

Comment

Angel P Sempere et al. N Engl J Med. 2013.

. 2013 Apr 25;368(17):1652.

doi: 10.1056/NEJMc1212740.

No abstract available

Comment in

Oral BG-12 in multiple sclerosis.
Fox RJ, Havrdova E. Fox RJ, et al. N Engl J Med. 2013 Apr 25;368(17):1652-3. doi: 10.1056/NEJMc1212740. N Engl J Med. 2013. PMID: 23614593 No abstract available.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators. Fox RJ, et al. N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328. N Engl J Med. 2012. PMID: 22992072 Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators. Gold R, et al. N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287. N Engl J Med. 2012. PMID: 22992073 Clinical Trial.